Krabbe disease, one of the autosomal-recessive lysosomal storage disorders (LSDs), is caused by a deficiency of galactocerebrosidase (GALC) activity, resulting in the intracellular accumulation of psychosine, which is cytotoxic for neuronal cells. Genetically pathogenic mutations result in conformational changes in GALC and disrupt the lysosmal trafficking of cargos, which subsequently accumulate in the endoplasmic reticulum (ER). Recently, ER stress together with the activation of the unfolded protein response (UPR) has been suggested to play a key role in the pathogenesis of LSDs. In this study, we hence investigated whether the UPR is activated in Krabbe disease using COS-7 cells expressing pathogenic GALC mutants and skin fibroblasts (SFs) from Krabbe disease patients with various phenotypes, using a combination of semiquantitative and quantitative real-time polymerase chain reactions. We found that UPR activation in Krabbe disease depends on the mutations and cell types, and there is the possibility that multiple pathways, involving ER chaperones, inositol-requiring kinase 1, and protein kinase regulated by RNA-like ER kinase are activated by mutations associated with the infantile form. These results indicate that in Krabbe disease, each misfolded/unfolded protein evokes different UPR activation depending on the mutation, and that the activated pathways affect the phenotypes.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s10038-018-0445-8DOI Listing

Publication Analysis

Top Keywords

krabbe disease
24
unfolded protein
8
protein response
8
activated krabbe
8
upr activation
8
krabbe
6
disease
6
activated
4
response activated
4
disease manner
4

Similar Publications

Background: Assessment of health-related quality of life (HRQoL) in patients with cardiovascular disease (CVD) is impaired by limitations of current patient-reported outcome measures (PROMs). We developed the first cardiovascular disease (CVD) specific electronic PROM for which health items were derived by a fully patient-centered method. This paper reports on the measurement of HRQoL in CVD patients by a novel developed electronic patient-centred PROM based on a preference-based measurement model.

View Article and Find Full Text PDF

Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease.

Sci Rep

December 2024

Department of Biotechnical and Clinical Laboratory Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, 14214, USA.

Lipocalin-2 (LCN2) is an acute-phase secretory molecule significantly upregulated in various neuroinflammatory and demyelinating conditions. Krabbe disease (KD) is a neurodegenerative lysosomal disorder caused by a galactosylceramidase (GALC) deficiency, accumulating cytotoxic psychosine in nervous systems, and subsequent neuroinflammation. Here, we show that LCN2 is highly overexpressed in GALC-deficient astrocytes.

View Article and Find Full Text PDF

A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy.

Mol Ther Nucleic Acids

December 2024

Department of Therapeutics for Multiple System Atrophy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Article Synopsis
  • The study highlights the challenge of delivering mRNA therapies effectively into oligodendrocytes, a type of brain cell, as traditional viral vectors aren't effective.
  • Researchers utilized LUNAR lipid nanoparticles to achieve high efficiency and specificity in delivering mRNA to these cells, leveraging low-density lipoprotein receptors with the help of apoprotein E.
  • A single dose of LUNAR-human galactosylceramidase mRNA significantly improved the health and survival of twitcher mice, a model for Krabbe disease, showcasing the potential of this method for treating neurological disorders related to oligodendrocytes.
View Article and Find Full Text PDF

Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease.

PLoS One

December 2024

Departments of Biochemistry and Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.

Article Synopsis
  • - Krabbe disease (Kd) is caused by a deficiency in the enzyme GALC, leading to the accumulation of the lipid galactosylceramide (GalCer), which produces a toxic lipid called psychosine that damages myelinating cells and leads to demyelination.
  • - Research using induced pluripotent stem cells (iPSCs) from Kd patients revealed that Kd myelinating organoids exhibit early myelination defects without affecting other cell types, while the microglia in these organoids show changes in response to GalCer feeding.
  • - The findings suggest that while Kd model organoids don't show classic lysosomal dysfunction, they provide an essential platform for studying the mechanisms behind demyel
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!